ASCO/ASH Clinical Practice Update: Erythropoiesis-stimulating agentsApril 15, 2019Patient & Survivor Care
CDC clarifies opioid prescribing guidelines in cancer, sickle cell diseaseApril 15, 2019Patient & Survivor CareOpioid Resource CenterPractice Management
In endometrial cancer and SUI, concomitant surgery improves outcomesApril 11, 2019Gynecologic CancerPatient & Survivor Care
Genetic variant increases stroke risk in childhood cancer survivorsApril 2, 2019Patient & Survivor CarePediatricsRare Diseases
Worse survival seen among black patients with MCLMarch 20, 2019Lymphoma & Plasma Cell DisordersPatient & Survivor Care
WISP: Early data provide further support for ISDO in women at high OC riskMarch 19, 2019Gynecologic CancerPatient & Survivor Care
Preliminary data show similar declines in worry, low regret with RRSO and RRS/RROMarch 18, 2019Gynecologic CancerPatient & Survivor Care
‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patientsMarch 14, 2019Patient & Survivor CarePractice Management
Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancerMarch 1, 2019Genitourinary CancerPatient & Survivor Care
Diet appears to play an important role in response to anti-PD-1 cancer immunotherapyMarch 1, 2019Immuno-oncologyMelanomaPatient & Survivor Care
AHA: Consider obesity as CVD risk factor in childrenFebruary 25, 2019PediatricsPatient & Survivor Care
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patientsFebruary 20, 2019Patient & Survivor Care
ADT harms likely limited to men with CV comorbiditiesFebruary 8, 2019Patient & Survivor CareGenitourinary Cancer
